Day 2

Negative ultrasensitive troponin T values may help discriminate patients with chest pain in the emergency

solaci
solaci
582
0

New laboratory tests can detect minimally elevated  levels few hours before regarding detection methodologies of previous generations.The hypothesis of this study is that patients with undetectable ultrasensitive troponin (

Conclusion

The undetectable ultrasensitive troponin T values in patients with chest pain and no signs of ischemia on the electrocardiogram has an accuracy close to 100% to rule out acute myocardial infarction regardless of the duration of symptoms, time of dosage of troponin , age or sex.

9_nadia_bandstein
Nadia Bandstein
2014-03-31

Original title: Negative High-Sensitive Troponins in the Emergency Department and Risk of Myocardial Infarction.

Previous article
CORP-2 Trial: Colchicine effective in reducing the recurrence of pericarditis associated withconventional anti-inflammatory pattern.
Next article
Melody
solaci
solaci

More articles by this author

CORP-2 Trial: Colchicine effective in reducing the recurrence of pericarditis associated withconventional anti-inflammatory pattern.

solaci - 0
Colchicine is effective in treating an acute pericarditis event and initial recurrences;however, there is no conclusive data on its efficacy and safety in the...

Melody

solaci - 0
The ducts of the right ventricle to the pulmonary artery are used in approximately 20 % of all patients with congenital defects including tetralogy...

LAPLACE 2: Evolocumab effective in reducing LDL associated with statins

solaci - 0
There are several patients who do not reach recommended LDL cholesterol despite maximally tolerated doses of statins levels.The Evolocumab is a monoclonal antibody that...

MADIT -CRT: Increased survival with resynchronization therapy plus defibrillator in patients with mild heart failure.

solaci - 0
The MADIT -CRT study (Multicenter Automatic Defibrillator Implantation with Cardiac Resynchronization Therapy) had shown that early intervention with cardiac resynchronization therapy plus defibrillator in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 2

CORP-2 Trial: Colchicine effective in reducing the recurrence of pericarditis associated withconventional anti-inflammatory pattern.

Colchicine is effective in treating an acute pericarditis event and initial recurrences;however, there is no conclusive data on its efficacy...
solaci -
SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Dr. Juan Manuel Pérez - 0
Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Dr. Juan Manuel Pérez - 0
Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Dr. Juan Manuel Pérez - 0
Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...